ロード中...
The Promise of Neuroprotective Agents in Parkinson’s Disease
Parkinson’s disease (PD) is characterized by loss of dopamine neurons in the substantia nigra of the brain. Since there are limited treatment options for PD, neuroprotective agents are currently being tested as a means to slow disease progression. Agents targeting oxidative stress, mitochondrial dys...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Research Foundation
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3221408/ https://ncbi.nlm.nih.gov/pubmed/22125548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2011.00068 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|